|
1
|
Shenouda MN, Sadek BT, Goldberg SI,
Keruakous AR, Croft BJ, Abi Raad RF and Taghian AG: Clinical
outcome of isolated locoregional recurrence in patients with breast
cancer according to their primary local treatment. Clin Breast
Cancer. 14:198–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akahane K, Tsunoda N, Murata T, Fujii M,
Fuwa Y, Wada K, Oda K and Nagino M: An awareness survey of surgeons
involved in breast cancer treatment regarding their patients
returning to work. Nagoya J Med Sci. 76:315–322. 2014.PubMed/NCBI
|
|
3
|
Barnard ME, Boeke CE and Tamimi RM:
Established breast cancer risk factors and risk of intrinsic tumor
subtypes. Biochim Biophys Acta. 1856:73–85. 2015.PubMed/NCBI
|
|
4
|
Acil H and Cavdar I: Comparison of quality
of life of Turkish breast cancer patients receiving breast
conserving surgery or modified radical mastectomy. Asian Pac J
Cancer Prev. 15:5377–5381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singleton TP, Perrone T, Oakley G, Niehans
GA, Carson L, Cha SS and Strickler JG: Activation of c-erbB-2 and
prognosis in ovarian carcinoma. Comparison with histologic type,
grade, and stage. Cancer. 73:1460–1466. 1994.
|
|
6
|
Zhao D, Pan C, Sun J, Gilbert C,
Drews-Elger K, Azzam DJ, Picon-Ruiz M, Kim M, Ullmer W, El-Ashry D,
et al: VEGF drives cancer-initiating stem cells through
VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene.
34:3107–3119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sauer T, Furu I, Beraki K, Jebsen PW,
Ormerod E and Naess O: nm23 protein expression in fine-needle
aspirates from breast carcinoma: Inverse correlation with cytologic
grading, lymph node status, and ploidy. Cancer. 84:109–114. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bao L, Cardiff RD, Steinbach P, Messer KS
and Ellies LG: Multipotent luminal mammary cancer stem cells model
tumor heterogeneity. Breast Cancer Res. 17:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jagadish N, Parashar D, Gupta N, Agarwal
S, Sharma A, Fatima R, Suri V, Kumar R, Gupta A, Lohiya NK, et al:
A novel cancer testis antigen target A-kinase anchor protein
(AKAP4) for the early diagnosis and immunotherapy of colon cancer.
OncoImmunology. 5:e10789652016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Youlden DR, Cramb SM, Dunn NA, Muller JM,
Pyke CM and Baade PD: The descriptive epidemiology of female breast
cancer: An international comparison of screening, incidence,
survival and mortality. Cancer Epidemiol. 36:237–248. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khan MA: Effect of preoperative
intravenous steroids on seroma formation after modified radical
mastectomy. J Ayub Med Coll Abbottabad. 29:207–210. 2017.PubMed/NCBI
|
|
12
|
Memmi EM, Sanarico AG, Giacobbe A,
Peschiaroli A, Frezza V, Cicalese A, Pisati F, Tosoni D, Zhou H,
Tonon G, et al: p63 sustains self-renewal of mammary cancer stem
cells through regulation of Sonic Hedgehog signaling. Proc Natl
Acad Sci USA. 112:3499–3504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thorsen LB, Offersen BV, Danø H, Berg M,
Jensen I, Pedersen AN, Zimmermann SJ, Brodersen HJ, Overgaard M and
Overgaard J: DBCG-IMN: A population-based cohort study on the
effect of internal mammary node irradiation in early node-positive
breast cancer. J Clin Oncol. 34:314–320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faustino-Rocha AI, Gama A, Oliveira PA,
Alvarado A, Fidalgo-Gonçalves L, Ferreira R and Ginja M:
Ultrasonography as the gold standard for in vivo volumetric
determination of chemically-induced mammary tumors. In Vivo.
30:465–472. 2016.PubMed/NCBI
|
|
15
|
Farabegoli F, Ceccarelli C, Santini D,
Baldini N, Taffurelli M, Marrano D, Treré D and Derenzini M:
c-erbB-2 over-expression in amplified and non-amplified breast
carcinoma samples. Int J Cancer. 84:273–277. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamnvik OP, Choueiri TK, Turchin A, McKay
RR, Goyal L, Davis M, Kaymakcalan MD and Williams JS: Clinical risk
factors for the development of hypertension in patients treated
with inhibitors of the VEGF signaling pathway. Cancer. 121:311–319.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ciamporcero E, Miles KM, Adelaiye R,
Ramakrishnan S, Shen L, Ku S, Pizzimenti S, Sennino B, Barrera G
and Pili R: Combination strategy targeting VEGF and HGF/c-met in
human renal cell carcinoma models. Mol Cancer Ther. 14:101–110.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin CH, Dammai V, Adryan B and Hsu T:
Interaction between Nm23 and the tumor suppressor VHL. Naunyn
Schmiedebergs Arch Pharmacol. 388:143–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ahmed M: Image-guided tumor ablation:
Standardization of terminology and reporting criteria - a 10-year
update: Supplement to the consensus document. J Vasc Interv Radiol.
25:1706–1708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simpson JF, O'Malley F, Dupont WD and Page
DL: Heterogeneous expression of nm23 gene product in noninvasive
breast carcinoma. Cancer. 73:2352–2358. 1994. View Article : Google Scholar : PubMed/NCBI
|
